Navigation Links
California Stem Cell Agency Exaggerated Its Role in Funding Key Research
Date:4/16/2008

Agency Claimed State Funding Led to Important Clinical Trials

SANTA MONICA, Calif., April 16 /PRNewswire-USNewswire/ -- California's stem cell agency overstated and hyped the importance of its funding in enabling clinical trials for a drug to treat a severe blood disorder, Consumer Watchdog said today, seriously undercutting the agency's credibility and alienating those who support publicly funded stem cell research.

Last week the California Institute For Regenerative Medicine (CIRM) issued a news release titled "First Clinical Trial Begins for a Therapy Enabled By CIRM Funding." The announcement even drew a comment from Gov. Arnold Schwarzenegger, who issued a release saying CIRM funding led to the discovery. He added, "I am proud of our state's commitment to stem cell research, which delivers the best promise in finding treatments for deadly and debilitating diseases."

A report on today's California Stem Cell Report published by David Jensen makes clear how little CIRM funding was actually involved in the research by a team led by UCSD's Catriona Jamieson.

"There is important scientific work here that led quickly to an important clinical trial," said John M. Simpson, director of Consumer Watchdog's Stem Cell Project. "But the fact is that CIRM is jumping on the bandwagon claiming credit for contributions that were at best rather trivial."

The initial CIRM news release about the clinical trial said that Jamieson was funded by a stem cell SEED grant that was approved in February 2007. That grant was given to fund the derivation of cancer-causing stem cells from human embryonic stem cells. The research that led to the clinical trial did not involve human embryonic stem cells at all.

Moreover, according to the official notice of grant award, the time period for the CIRM funded grant of $613,305 was from Aug. 1, 2007- July 31, 2009. The university officially signed off on the grant on Aug. 31, 2007. The paper
'/>"/>

SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
2. New Conflict of Interest Violations Revealed at California Stem Cell Institute
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
5. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
6. Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
9. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
10. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
11. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)... Showed Larazotide Acetate Prevented Immunologic C...ts with Celiac Disease, Additional Data Indicates ... ORLANDO, Fla., Oct. 7 /- Alba Therap...ical studies this week at the American,College of ...ing. Data from,study CLIN 1001-004, the first Phas...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific ...tCall/ -- Ironwood,Pharmaceuticals, Inc. (formerly...SE: FRX ) today announced the presentation of res... safety and efficacy in 420 patients with,irritabl...is of the data,indicates that once- daily oral dos...
(Date:10/7/2008)...ient, Prospective Randomized Placebo-Controlled Ph...ant Improved Overall Survival., MOUNTAIN VIEW, Ca...peutics has now evaluated the mature Phase II data...idate PROSTVAC(TM) that had been,obtained as part ...nal,Cancer Institute (NCI) in the US., The result...
(Date:10/7/2008)...STGÃ…RD, Denmark, October 7 /PRNewswire-FirstCall/...o-Controlled Phase II Study,Shows Statistically Si...dic has now evaluated the mature phase II data fro...e PROSTVAC(TM) that had been,obtained as part of t...Cancer Institute (NCI) in the US., The results fr...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5NIST announces 56 new awards for innovative technology research and development 604 1iCAD to Present at William Blair 26 Company Small Cap Growth Stock Conference 2321 1iCAD to Present at William Blair 26 Company Small Cap Growth Stock Conference 2321 2President Bush Should Protect Kids Not Big Tobacco By Signing Bill to Increase Cigarette Tax Fund SCHIP 2318 1President Bush Should Protect Kids Not Big Tobacco By Signing Bill to Increase Cigarette Tax Fund SCHIP 2318 2Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals 932 1Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals 932 2
(Date:10/7/2008)...ltrasound similar to more expensive whole-leg colo...AY, Oct. 7 (HealthDay News) -- An older, simpler t...eep vein thrombosis, or DVT -- is as effective as ..., European researchers found that 2-point ultras...on or duplex ultrasound -- was as good at detectin...
(Date:10/7/2008)...riz., Oct. 7 /PRNewswire/ -- Join Mii amo, a desti...elebration in Sedona,s red rock,country honoring t...ude a,series of traditional Native American ceremo...or R.J. Joseph and special guest, Elder George,Goo...oot Elder from the Blood Reserve,in Standoff, Albe...
(Date:10/7/2008)... 100,000 PEOPLE ACROSS THE NATION HAVE SAID ,I VOT... DALLAS, Oct. 7 /PRNewswire/ -- To aid and help e...out the positions of presidential candidates,Senat...e and cancer issues,the Susan G. Komen for the Cu... resources available on its web site --, http://ww...
(Date:10/7/2008)...N, Oct. 7 /PRNewswire-USNewswire/ -- The Catholic ...n conjunction with Catholic,Health Initiatives (CH...;,and Trinity Health, Novi, MI -- is launching a m...l climate change., Through receipt of a $20,000 g...he Environment (NRPE) and the Catholic Coalition o...
Breaking Medicine News(10 mins):Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2
...sts have developed a scan that could spot the earl...ated illness.// The new machine, which uses techno...of liver damage drinkers may be doing themselves, ...n of Daily Mail. Until now damage could be accurat...
...ing fatty dairy products may actually help in slim... specialists have cautioned people to be wary of s...nvolved in this study. At the end of this study, i...fat free milk had put on more weight when compared...
...re many agencies which are involved in different k...research findings. Each agency may come out with d...the funding agency. In this connection, Dr. David...nd Harvard University says that there are numerous...
...ampsia, an extremely undesirable condition in preg...and child. The condition is said to claim the live...scientists have devised a new diagnostic evaluatio...cting the condition early and saving lives. The r...
Other Medicine News:
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: